US stock anomaly | Reached a $11 billion partnership agreement with Seegene BioNTech (BNTX.US) soared nearly 15%

According to Zhtng Cijng APP, on Monday, BioNTech (BNTX.US) opened up nearly 15% at $109.54 per share. In terms of news, it was reported that Bristol-Myers Squibb (BMY.US) will pay up to $11 billion to BioNTech SE to obtain a license for a next-generation cancer drug. Both companies announced on Monday that BioNTech will receive $1.5 billion in upfront payments and $2 billion in milestone payments until 2028. BioNTech will also be eligible for up to $7.6 billion in milestone payments, with partners sharing development and manufacturing costs and profits.